Macrophage

Macrophages were first discovered and named by Élie Metchnikoff, a Russian Empire zoologist, in 1884.^[10][11]

Structure

Types

A majority of macrophages are stationed at strategic points where microbial invasion or accumulation of foreign particles is likely to occur. These cells together as a group are known as the mononuclear phagocyte system and were previously known as the reticuloendothelial system. Each type of macrophage, determined by its location, has a specific name:

Investigations concerning Kupffer cells are hampered because in humans, Kupffer cells are only accessible for immunohistochemical analysis from biopsies or autopsies. From rats and mice, they are difficult to isolate, and after purification, only approximately 5 million cells can be obtained from one mouse.

Macrophages can express

Macrophages can be classified on basis of the fundamental function and activation. According to this grouping, there are classically activated (M1) macrophages, wound-healing macrophages (also known as alternatively-activated (M2) macrophages), and regulatory macrophages (Mregs).^[18]

Development

Macrophages that reside in adult healthy tissues either derive from circulating monocytes or are established before birth and then maintained during adult life independently of monocytes.

Function

Phagocytosis

Macrophages are professional phagocytes and are highly specialized in removal of dying or dead cells and cellular debris. This role is important in chronic inflammation, as the early stages of inflammation are dominated by neutrophils, which are ingested by macrophages if they come of age (see CD31 for a description of this process).^[23]

The neutrophils are at first attracted to a site, where they perform their function and die, before they or their neutrophil extracellular traps are phagocytized by the macrophages.^[23][24] When at the site, the first wave of neutrophils, after the process of aging and after the first 48 hours, stimulate the appearance of the macrophages whereby these macrophages will then ingest the aged neutrophils.^[23]

The removal of dying cells is, to a greater extent, handled by fixed macrophages, which will stay at strategic locations such as the lungs, liver, neural tissue, bone, spleen and connective tissue, ingesting foreign materials such as pathogens and recruiting additional macrophages if needed.^[25]

When a macrophage ingests a pathogen, the pathogen becomes trapped in a

When a pathogen invades, tissue resident macrophages are among the first cells to respond.[27] Two of the main roles of the tissue resident macrophages are to phagocytose incoming antigen and to secrete proinflammatory cytokines that induce inflammation and recruit other immune cells to the site.^[28]

Phagocytosis of pathogens

Macrophages can internalize antigens through receptor-mediated phagocytosis.[29] Macrophages have a wide variety of pattern recognition receptors (PRRs) that can recognize microbe-associated molecular patterns (MAMPs) from pathogens. Many PRRs, such as toll-like receptors (TLRs), scavenger receptors (SRs), C-type lectin receptors, among others, recognize pathogens for phagocytosis.^[29] Macrophages can also recognize pathogens for phagocytosis indirectly through opsonins, which are molecules that attach to pathogens and mark them for phagocytosis.^[30] Opsonins can cause a stronger adhesion between the macrophage and pathogen during phagocytosis, hence opsonins tend to enhance macrophages’ phagocytic activity.^[31] Both complement proteins and antibodies can bind to antigens and opsonize them. Macrophages have complement receptor 1 (CR1) and 3 (CR3) that recognize pathogen-bound complement proteins C3b and iC3b, respectively, as well as fragment crystallizable γ receptors (FcγRs) that recognize the fragment crystallizable (Fc) region of antigen-bound immunoglobulin G (IgG) antibodies.^[30][32] When phagocytosing and digesting pathogens, macrophages go through a respiratory burst where more oxygen is consumed to supply the energy required for producing reactive oxygen species (ROS) and other antimicrobial molecules that digest the consumed pathogens.^[28][33]

Cytokine secretion

Recognition of MAMPs by PRRs can activate tissue resident macrophages to secrete proinflammatory cytokines that recruit other immune cells. Among the PRRs, TLRs play a major role in signal transduction leading to cytokine production.^[29] The binding of MAMPs to TLR triggers a series of downstream events that eventually activates transcription factor NF-κB and results in transcription of the genes for several proinflammatory cytokines, including IL-1β, IL-6, TNF-α, IL-12B, and type I interferons such as IFN-α and IFN-β.^[34] Systemically, IL-1β, IL-6, and TNF-α induce fever and initiate the acute phase response in which the liver secretes acute phase proteins.^[27][28][35] Locally, IL-1β and TNF-α cause vasodilation, where the gaps between blood vessel epithelial cells widen, and upregulation of cell surface adhesion molecules on epithelial cells to induce leukocyte extravasation.^[27][28]

Neutrophils are among the first immune cells recruited by macrophages to exit the blood via extravasation and arrive at the infection site.^[35] Macrophages secrete many chemokines such as CXCL1, CXCL2, and CXCL8 (IL-8) that attract neutrophils to the site of infection.^[27][35] After neutrophils have finished phagocytosing and clearing the antigen at the end of the immune response, they undergo apoptosis, and macrophages are recruited from blood monocytes to help clear apoptotic debris.^[36]

Macrophages also recruit other immune cells such as monocytes, dendritic cells, natural killer cells, basophils, eosinophils, and T cells through chemokines such as CCL2, CCL4, CCL5, CXCL8, CXCL9, CXCL10, and CXCL11.^[27][35] Along with dendritic cells, macrophages help activate natural killer (NK) cells through secretion of type I interferons (IFN-α and IFN-β) and IL-12. IL-12 acts with IL-18 to stimulate the production of proinflammatory cytokine interferon gamma (IFN-γ) by NK cells, which serves as an important source of IFN-γ before the adaptive immune system is activated.^[35][37] IFN-γ enhances the innate immune response by inducing a more aggressive phenotype in macrophages, allowing macrophages to more efficiently kill pathogens.^[35]

Some of the T cell chemoattractants secreted by macrophages include CCL5, CXCL9, CXCL10, and CXCL11.^[27]

Role in adaptive immunity

Interactions with CD4⁺ T Helper Cells

Macrophages are professional antigen presenting cells (APC), meaning they can present peptides from phagocytosed antigens on major histocompatibility complex (MHC) II molecules on their cell surface for T helper cells.^[39] Macrophages are not primary activators of naïve T helper cells that have never been previously activated since tissue resident macrophages do not travel to the lymph nodes where naïve T helper cells reside.^[40][41] Although macrophages are also found in secondary lymphoid organs like the lymph nodes, they do not reside in T cell zones and are not effective at activating naïve T helper cells.^[40] The macrophages in lymphoid tissues are more involved in ingesting antigens and preventing them from entering the blood, as well as taking up debris from apoptotic lymphocytes.^[40][42] Therefore, macrophages interact mostly with previously activated T helper cells that have left the lymph node and arrived at the site of infection or with tissue resident memory T cells.^[41]

Macrophages supply both signals required for T helper cell activation: 1) Macrophages present antigen peptide-bound MHC class II molecule to be recognized by the corresponding T cell receptor (TCR), and 2) recognition of pathogens by PRRs induce macrophages to upregulate the co-stimulatory molecules CD80 and CD86 (also known as B7) that binds to CD28 on T helper cells to supply the co-stimulatory signal.^[35][39] These interactions allow T helper cells to achieve full effector function and provide T helper cells with continued survival and differentiation signals preventing them from undergoing apoptosis due to lack of TCR signaling.^[39] For example, IL-2 signaling in T cells upregulates the expression of anti-apoptotic protein Bcl-2, but T cell production of IL-2 and the high-affinity IL-2 receptor IL-2RA both require continued signal from TCR recognition of MHC-bound antigen.^[35][43]

Activation

Macrophages can achieve different activation phenotypes through interactions with different subsets of T helper cells, such as T_H1 and T_H2.^[18] Although there is a broad spectrum of macrophage activation phenotypes, there are two major phenotypes that are commonly acknowledged.^[18] They are the classically activated macrophages, or M1 macrophages, and the alternatively activated macrophages, or M2 macrophages. M1 macrophages are proinflammatory, while M2 macrophages are mostly anti-inflammatory.^[18]

Classical

T_H1 cells play an important role in classical macrophage activation as part of type 1 immune response against intracellular pathogens (such as intracellular bacteria) that can survive and replicate inside host cells, especially those pathogens that replicate even after being phagocytosed by macrophages.^[44] After the TCR of T_H1 cells recognize specific antigen peptide-bound MHC class II molecules on macrophages, T_H1 cells 1) secrete IFN-γ and 2) upregulate the expression of CD40 ligand (CD40L), which binds to CD40 on macrophages.^[45][35] These 2 signals activate the macrophages and enhance their ability to kill intracellular pathogens through increased production of antimicrobial molecules such as nitric oxide (NO) and superoxide (O^2-).^[27][35] This enhancement of macrophages' antimicrobial ability by T_H1 cells is known as classical macrophage activation, and the activated macrophages are known as classically activated macrophages, or M1 macrophages. The M1 macrophages in turn upregulates B7 molecules and antigen presentation through MHC class II molecules to provide signals that sustain T cell help.^[45] The activation of T_H1 and M1 macrophage is a positive feedback loop, with IFN-γ from T_H1 cells upregulating CD40 expression on macrophages; the interaction between CD40 on the macrophages and CD40L on T cells activate macrophages to secrete IL-12; and IL-12 promotes more IFN-γ secretion from T_H1 cells.^[35][45] The initial contact between macrophage antigen-bound MHC II and TCR serves as the contact point between the two cells where most of the IFN-γ secretion and CD-40L on T cells concentrate to, so only macrophages directly interacting with T_H1 cells are likely to be activated.^[35]

In addition to activating M1 macrophages, T_H1 cells express Fas ligand (FasL) and lymphotoxin beta (LT-β) to help kill chronically infected macrophages that can no longer kill pathogens.^[35] The killing of chronically infected macrophages release pathogens to the extracellular space that can then be killed by other activated macrophages.^[35] T_H1 cells also help recruit more monocytes, the precursor to macrophages, to the infection site. T_H1 secretion TNF-α and LT-α to make blood vessels easier for monocytes to bind to and exit.^[35] T_H1 secretion of CCL2 as a chemoattractant for monocytes. IL-3 and GM-CSF released by T_H1 cells stimulate more monocyte production in the bone marrow.^[35]

When intracellular pathogens cannot be eliminated, such as in the case of Mycobacterium tuberculosis, the pathogen is contained through the formation of granuloma, an aggregation of infected macrophages surrounded by activated T cells.^[46] The macrophages bordering the activated lymphocytes often fuse to form multinucleated giant cells that appear to have increased antimicrobial ability due to their proximity to T_H1 cells, but over time, the cells in the center start to die and form necrotic tissue.^[41][46]

Alternative

T_H2 cells play an important role in alternative macrophage activation as part of type 2 immune response against large extracellular pathogens like helminths.^[35][47] T_H2 cells secrete IL-4 and IL-13, which activate macrophages to become M2 macrophages, also known as alternatively activated macrophages.^[47][48] M2 macrophages express arginase-1, an enzyme that converts arginine to ornithine and urea.^[47] Ornithine help increase smooth muscle contraction to expel the worm and also participates in tissue and wound repair. Ornithine can be further metabolized to proline, which is essential for synthesizing collagen.^[47] M2 macrophages can also decrease inflammation by producing IL-1 receptor antagonist (IL-1RA) and IL-1 receptors that do not lead to downstream inflammatory signaling (IL-1RII).^[35][49]

Interactions with CD8⁺ cytotoxic t cells

Another part of the adaptive immunity activation involves stimulating CD8⁺ via cross presentation of antigens peptides on MHC class I molecules. Studies have shown that proinflammatory macrophages are capable of cross presentation of antigens on MHC class I molecules, but whether macrophage cross-presentation plays a role in naïve or memory CD8⁺ T cell activation is still unclear.^[28][50][42]

Interactions with B cells

Macrophages have been shown to secrete cytokines BAFF and APRIL, which are important for plasma cell isotype switching. APRIL and IL-6 secreted by macrophage precursors in the bone marrow help maintain survival of plasma cells homed to the bone marrow.^[51]

Subtypes

alveolar macrophages shown above (white arrows). A "siderophage" contains hemosiderin (also shown by black arrow in left image), while anthracotic macrophages result from coal dust inhalation (and also long-term air pollution).^[52] H&E stain

.

There are several activated forms of macrophages.

IFN-gamma, and secrete high levels of IL-12 and low levels of IL-10. M1 macrophages have pro-inflammatory, bactericidal, and phagocytic functions.^[54] In contrast, the M2 "repair" designation (also referred to as alternatively activated macrophages) broadly refers to macrophages that function in constructive processes like wound healing and tissue repair, and those that turn off damaging immune system activation by producing anti-inflammatory cytokines like IL-10. M2 is the phenotype of resident tissue macrophages, and can be further elevated by IL-4. M2 macrophages produce high levels of IL-10, TGF-beta and low levels of IL-12. Tumor-associated macrophages are mainly of the M2 phenotype, and seem to actively promote tumor growth.^[55]

Macrophages exist in a variety of phenotypes which are determined by the role they play in wound maturation. Phenotypes can be predominantly separated into two major categories; M1 and M2. M1 macrophages are the dominating phenotype observed in the early stages of inflammation and are activated by four key mediators: interferon-γ (IFN-γ), tumor necrosis factor (TNF), and damage associated molecular patterns (DAMPs). These mediator molecules create a pro-inflammatory response that in return produce pro-inflammatory cytokines like Interleukin-6 and TNF. Unlike M1 macrophages, M2 macrophages secrete an anti-inflammatory response via the addition of Interleukin-4 or Interleukin-13. They also play a role in wound healing and are needed for revascularization and reepithelialization. M2 macrophages are divided into four major types based on their roles: M2a, M2b, M2c, and M2d. How M2 phenotypes are determined is still up for discussion but studies have shown that their environment allows them to adjust to whichever phenotype is most appropriate to efficiently heal the wound.[54]

M2 macrophages are needed for vascular stability. They produce vascular endothelial growth factor-A and TGF-β1.^[54] There is a phenotype shift from M1 to M2 macrophages in acute wounds, however this shift is impaired for chronic wounds. This dysregulation results in insufficient M2 macrophages and its corresponding growth factors that aid in wound repair. With a lack of these growth factors/anti-inflammatory cytokines and an overabundance of pro-inflammatory cytokines from M1 macrophages chronic wounds are unable to heal in a timely manner. Normally, after neutrophils eat debris/pathogens they perform apoptosis and are removed. At this point, inflammation is not needed and M1 undergoes a switch to M2 (anti-inflammatory). However, dysregulation occurs as the M1 macrophages are unable/do not phagocytose neutrophils that have undergone apoptosis leading to increased macrophage migration and inflammation.^[54]

Both M1 and M2 macrophages play a role in promotion of

foam cells contributing to the atheromatous plaque of atherosclerosis.^[56][57]

Role in muscle regeneration

The first step to understanding the importance of macrophages in muscle repair, growth, and regeneration is that there are two "waves" of macrophages with the onset of damageable muscle use– subpopulations that do and do not directly have an influence on repairing muscle. The initial wave is a phagocytic population that comes along during periods of increased muscle use that are sufficient to cause muscle membrane lysis and membrane inflammation, which can enter and degrade the contents of injured muscle fibers.[58]^[59][60] These early-invading, phagocytic macrophages reach their highest concentration about 24 hours following the onset of some form of muscle cell injury or reloading.^[61] Their concentration rapidly declines after 48 hours.^[59] The second group is the non-phagocytic types that are distributed near regenerative fibers. These peak between two and four days and remain elevated for several days during while muscle tissue is rebuilding.^[59] The first subpopulation has no direct benefit to repairing muscle, while the second non-phagocytic group does.

It is thought that macrophages release soluble substances that influence the proliferation, differentiation, growth, repair, and regeneration of muscle, but at this time the factor that is produced to mediate these effects is unknown.^[61] It is known that macrophages' involvement in promoting tissue repair is not muscle specific; they accumulate in numerous tissues during the healing process phase following injury.^[62]

Role in wound healing

Macrophages are essential for

polymorphonuclear neutrophils as the predominant cells in the wound by day two after injury.^[64] Attracted to the wound site by growth factors released by platelets and other cells, monocytes from the bloodstream enter the area through blood vessel walls.^[65] Numbers of monocytes in the wound peak one to one and a half days after the injury occurs. Once they are in the wound site, monocytes mature into macrophages. The spleen contains half the body's monocytes in reserve ready to be deployed to injured tissue.^[66][67]

The macrophage's main role is to phagocytize bacteria and damaged tissue,

better source needed

] By secreting these factors, macrophages contribute to pushing the wound healing process into the next phase.

Role in limb regeneration

Scientists have elucidated that as well as eating up material debris, macrophages are involved in the typical

limb regeneration in the salamander.^[73][74] They found that removing the macrophages from a salamander resulted in failure of limb regeneration and a scarring response.^[73][74]

Role in iron homeostasis

Main article: Human iron metabolism

As described above, macrophages play a key role in removing dying or dead cells and cellular debris.

parenteral irons.^{[citation needed}

]

The iron that is released from the haemoglobin is either stored internally in ferritin or is released into the circulation via ferroportin. In cases where systemic iron levels are raised, or where inflammation is present, raised levels of hepcidin act on macrophage ferroportin channels, leading to iron remaining within the macrophages.^{[citation needed]}

Role in pigment retainment

Melanophages are a subset of tissue-resident macrophages able to absorb pigment, either native to the organism or exogenous (such as tattoos), from extracellular space. In contrast to dendritic juncional melanocytes, which synthesize melanosomes and contain various stages of their development, the melanophages only accumulate phagocytosed melanin in lysosome-like phagosomes.^[75][76] This occurs repeatedly as the pigment from dead dermal macrophages is phagocytosed by their successors, preserving the tattoo in the same place.^[77]

Role in tissue homeostasis

Every tissue harbors its own specialized population of resident macrophages, which entertain reciprocal interconnections with the stroma and functional tissue.^[78][79] These resident macrophages are sessile (non-migratory), provide essential growth factors to support the physiological function of the tissue (e.g. macrophage-neuronal crosstalk in the guts),^[80] and can actively protect the tissue from inflammatory damage.^[81]

Nerve-associated macrophages

Nerve-associated macrophages or NAMs are those tissue-resident macrophages that are associated with nerves. Some of them are known to have an elongated morphology of up to 200μm ^[82]

Clinical significance

Due to their role in phagocytosis, macrophages are involved in many diseases of the immune system. For example, they participate in the formation of granulomas, inflammatory lesions that may be caused by a large number of diseases. Some disorders, mostly rare, of ineffective phagocytosis and macrophage function have been described, for example.^[83]

As a host for intracellular pathogens

In their role as a phagocytic immune cell macrophages are responsible for engulfing pathogens to destroy them. Some pathogens subvert this process and instead live inside the macrophage. This provides an environment in which the pathogen is hidden from the immune system and allows it to replicate.^{[citation needed]}

Diseases with this type of behaviour include tuberculosis (caused by Mycobacterium tuberculosis) and leishmaniasis (caused by Leishmania species).^{[citation needed]}

In order to minimize the possibility of becoming the host of an intracellular bacteria, macrophages have evolved defense mechanisms such as induction of nitric oxide and reactive oxygen intermediates,^[84] which are toxic to microbes. Macrophages have also evolved the ability to restrict the microbe's nutrient supply and induce autophagy.^[85]

Tuberculosis

Once engulfed by a macrophage, the causative agent of tuberculosis, Mycobacterium tuberculosis,^[86] avoids cellular defenses and uses the cell to replicate. Recent evidence suggests that in response to the pulmonary infection of Mycobacterium tuberculosis, the peripheral macrophages matures into M1 phenotype. Macrophage M1 phenotype is characterized by increased secretion of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6) and increased glycolytic activities essential for clearance of infection.^[1]

Leishmaniasis

Upon phagocytosis by a macrophage, the Leishmania parasite finds itself in a phagocytic vacuole. Under normal circumstances, this phagocytic vacuole would develop into a lysosome and its contents would be digested. Leishmania alter this process and avoid being destroyed; instead, they make a home inside the vacuole.^{[citation needed]}

Chikungunya

Infection of macrophages in joints is associated with local inflammation during and after the acute phase of Chikungunya (caused by CHIKV or Chikungunya virus).^[87]

Others

Adenovirus (most common cause of pink eye) can remain latent in a host macrophage, with continued viral shedding 6–18 months after initial infection.^{[citation needed}

]

Brucella spp. can remain latent in a macrophage via inhibition of phagosome–lysosome fusion; causes brucellosis (undulant fever).^{[citation needed]}

Legionella pneumophila, the causative agent of Legionnaires' disease, also establishes residence within macrophages.^{[citation needed]}

Heart disease

Macrophages are the predominant cells involved in creating the progressive plaque lesions of atherosclerosis.^[88]

Focal recruitment of macrophages occurs after the onset of acute myocardial infarction. These macrophages function to remove debris, apoptotic cells and to prepare for tissue regeneration.^[89] Macrophages protect against ischemia-induced ventricular tachycardia in hypokalemic mice.^[90]

HIV infection

Macrophages also play a role in

T cells, macrophages can be infected with HIV, and even become a reservoir of ongoing virus replication throughout the body. HIV can enter the macrophage through binding of gp120 to CD4 and second membrane receptor, CCR5 (a chemokine receptor). Both circulating monocytes and macrophages serve as a reservoir for the virus.^[91] Macrophages are better able to resist infection by HIV-1 than CD4+ T cells, although susceptibility to HIV infection differs among macrophage subtypes.^[92]

Cancer

Macrophages can contribute to tumor growth and progression by promoting tumor cell proliferation and invasion, fostering tumor angiogenesis and suppressing antitumor immune cells.

IL-1 and IL-6,^[96]

contributing further to the tumor growth.

Macrophages have been shown to infiltrate a number of tumors. Their number correlates with poor prognosis in certain cancers, including cancers of breast, cervix, bladder, brain and prostate.

Angiotensin II, that trigger the amplification and mobilization of macrophages in tumors.^{[99][100][101]} Additionally, subcapsular sinus macrophages in tumor-draining lymph nodes can suppress cancer progression by containing the spread of tumor-derived materials.^[102]

Cancer therapy

Experimental studies indicate that macrophages can affect all therapeutic modalities, including

radiotherapy, immunotherapy and targeted therapy.^{[94][103][104]} Macrophages can influence treatment outcomes both positively and negatively. Macrophages can be protective in different ways: they can remove dead tumor cells (in a process called phagocytosis) following treatments that kill these cells; they can serve as drug depots for some anticancer drugs;^[105] they can also be activated by some therapies to promote antitumor immunity.^[106] Macrophages can also be deleterious in several ways: for example they can suppress various chemotherapies,^[107][108] radiotherapies^[109][110] and immunotherapies.^[111][112] Because macrophages can regulate tumor progression, therapeutic strategies to reduce the number of these cells, or to manipulate their phenotypes, are currently being tested in cancer patients.^[113][114] However, macrophages are also involved in antibody mediated cytotoxicity (ADCC) and this mechanism has been proposed to be important for certain cancer immunotherapy antibodies.^[115]

Obesity

It has been observed that increased number of pro-inflammatory macrophages within obese adipose tissue contributes to obesity complications including insulin resistance and diabetes type 2.[116]

The modulation of the inflammatory state of adipose tissue macrophages has therefore been considered a possible therapeutic target to treat obesity-related diseases.^[117] Although adipose tissue macrophages are subject to anti-inflammatory homeostatic control by sympathetic innervation, experiments using ADRB2 gene knockout mice indicate that this effect is indirectly exerted through the modulation of adipocyte function, and not through direct Beta-2 adrenergic receptor activation, suggesting that adrenergic stimulation of macrophages may be insufficient to impact adipose tissue inflammation or function in obesity.^[118]

Within the fat (adipose) tissue of CCR2 deficient mice, there is an increased number of eosinophils, greater alternative macrophage activation, and a propensity towards type 2 cytokine expression. Furthermore, this effect was exaggerated when the mice became obese from a high fat diet.^[119] This is partially caused by a phenotype switch of macrophages induced by necrosis of fat cells (adipocytes). In an obese individual some adipocytes burst and undergo necrotic death, which causes the residential M2 macrophages to switch to M1 phenotype. This is one of the causes of a low-grade systemic chronic inflammatory state associated with obesity.^[120][121]

Intestinal macrophages

Though very similar in structure to tissue macrophages, intestinal macrophages have evolved specific characteristics and functions given their natural environment, which is in the digestive tract. Macrophages and intestinal macrophages have high plasticity causing their phenotype to be altered by their environments.^[122] Like macrophages, intestinal macrophages are differentiated monocytes, though intestinal macrophages have to coexist with the microbiome in the intestines. This is a challenge considering the bacteria found in the gut are not recognized as "self" and could be potential targets for phagocytosis by the macrophage.^[123]

To prevent the destruction of the gut bacteria, intestinal macrophages have developed key differences compared to other macrophages. Primarily, intestinal macrophages do not induce inflammatory responses. Whereas tissue macrophages release various inflammatory cytokines, such as IL-1, IL-6 and TNF-α, intestinal macrophages do not produce or secrete inflammatory cytokines. This change is directly caused by the intestinal macrophages environment. Surrounding intestinal epithelial cells release TGF-β, which induces the change from proinflammatory macrophage to noninflammatory macrophage.^[123]

Even though the inflammatory response is downregulated in intestinal macrophages, phagocytosis is still carried out. There is no drop off in phagocytosis efficiency as intestinal macrophages are able to effectively phagocytize the bacteria,S. typhimurium and E. coli, but intestinal macrophages still do not release cytokines, even after phagocytosis. Also, intestinal macrophages do not express lipopolysaccharide (LPS), IgA, or IgG receptors.^[124] The lack of LPS receptors is important for the gut as the intestinal macrophages do not detect the microbe-associated molecular patterns (MAMPS/PAMPS) of the intestinal microbiome. Nor do they express IL-2 and IL-3 growth factor receptors.^[123]

Role in disease

Intestinal macrophages have been shown to play a role in inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC). In a healthy gut, intestinal macrophages limit the inflammatory response in the gut, but in a disease-state, intestinal macrophage numbers and diversity are altered. This leads to inflammation of the gut and disease symptoms of IBD. Intestinal macrophages are critical in maintaining gut homeostasis. The presence of inflammation or pathogen alters this homeostasis, and concurrently alters the intestinal macrophages.^[125] There has yet to be a determined mechanism for the alteration of the intestinal macrophages by recruitment of new monocytes or changes in the already present intestinal macrophages.^[124]

Additionally, a new study reveals macrophages limit iron access to bacteria by releasing extracellular vesicles, improving sepsis outcomes.^[126]

Media

• An active J774 macrophage is seen taking up four

  interferon-γ

  one night before filming with conidia. Observations were made every 30s over a 2.5hr period.
• Two highly active

  conidia

  . Time lapse is 30s per frame over 2.5hr.

History

This section needs expansion. You can help by adding to it. (March 2018)

Macrophages were first discovered late in the 19th century by Élie Metchnikoff.^[127]Élie Metchnikoff revolutionized the branch of macrophages by combining philosophical insights and the evolutionary study of life.^[128] Later on, Van Furth during the 1960s proposed the idea that circulating blood monocytes in adults allowed for the origin of all tissue macrophages.^[129] In recent years, publishing regarding macrophages has led people to believe that multiple resident tissue macrophages are independent of the blood monocytes as it is formed during the embryonic stage of development.^[130] Within the 21st century, all the ideas concerning the origin of macrophages (present in tissues) are compiled together to suggest that physiologically complex organisms, form macrophages independently by mechanisms that don't have to depend on the blood monocytes.^[131]

See also

• Bacteriophage
• Dendritic cell
• Histiocyte
• List of distinct cell types in the adult human body

References

1. ^
   S2CID 231437641
   .
2. ^ "Regenerative Medicine Partnership in Education". Archived from the original on 25 April 2015. Retrieved 7 May 2015.
3. PMID 33076700
   .
4. S2CID 38894501
   . Macrophages are present essentially in all tissues, beginning with embryonic development and, in addition to their role in host defense and in the clearance of apoptotic cells, are being increasingly recognized for their trophic function and role in regeneration.
5. PMID 23428224
   .
6. ISBN 978-0-8153-4551-0
   .
7. S2CID 27541569
   .
8. PMID 9400735
   .
9. S2CID 6066984
   .
10. ISBN 978-0-89875-622-7
    .
11. S2CID 3621509
    .
12. ^ Lote CJ. Principles of Renal Physiology, 5th edition. Springer. p. 37.
13. PMID 36410109
    .
14. PMID 25921539
    .
15. PMID 36450771
    .
16. PMID 10698170
    .
17. PMID 28431249
    .
18. ^
    PMID 19029990
    .
19. PMID 26681456
    .
20. PMID 26982352
    .
21. PMID 24673186
    .
22. PMID 33372158
    .
23. ^
    PMID 17299434
    . =Monocytes/macrophages. Unless stimuli for neutrophil recruitment persist at the wound site, the neutrophil infiltration ceases after few days, and expended neutrophils are themselves phagocytosed by macrophages, which are present at the wound side within 2 days after injury.
24. PMID 34516771
    .
25. ISSN 2250-1177
    .
26. ^ YashRoy RC (2000). "Hijacking of Macrophages by Salmonella (310r) Through 'Types III' Secretion Like Exocytotic Signalling : A Mechanism for Infection of Chicken Ileum". Indian Journal of Poultry Science. 35 (3): 276–281.
27. ^
    PMID 25339958
    .
28. ^
    ISBN 978-1-4641-8978-4
    .
29. ^
    PMID 33995386
    .
30. ^
    PMID 29286292
    .
31. PMID 32582172
    .
32. S2CID 29387085
    .
33. S2CID 22246117
    .
34. PMID 29158945
    .
35. ^
    ISBN 978-0-393-88487-6
    .
36. PMID 17299434
    .
37. S2CID 219622032
    .
38. PMID 17620618
    .
39. ^
    PMID 30635094
    .
40. ^
    S2CID 10305140
    .
41. ^
    ISBN 978-0-8153-4505-3
    .
42. ^
    PMID 22488251
    .
43. S2CID 221280663
    .
44. PMID 25528359
    .
45. ^
    PMID 34248982
    .
46. ^
    PMID 25309534
    .
47. ^
    PMID 30057915
    .
48. S2CID 23185583
    .
49. PMID 23195532
    .
50. PMID 32733446
    .
51. PMID 24432021
    .
52. ISBN 978-0-7216-7335-6
    .
53. ^ "The lymphocyte story". New Scientist (1605). Retrieved 13 September 2007.
54. ^
    PMID 28714933
    .
55. S2CID 41189572
    .
56. PMID 20376052
    .
57. PMID 22356914
    .
58. S2CID 23012375
    .
59. ^
    PMID 7961247
    .
60. S2CID 23315528
    .
61. ^ ^{a b} Schiaffino S, Partridge T (2008). Skeletal Muscle Repair and Regeneration. Advances in Muscle Research. Vol. 3.
62. PMID 19079608
    .
63. ^ ^{a b} de la Torre J., Sholar A. (2006). Wound healing: Chronic wounds. Emedicine.com. Accessed 20 January 2008.
64. ^ "The phases of cutaneous wound healing" (PDF). Expert Reviews in Molecular Medicine. 5. Cambridge University Press. 21 March 2003. Archived from the original (PDF) on 17 December 2008.
65. ISBN 978-0-387-22744-3. Archived from the original
    (PDF) on 31 October 2005.
66. PMID 19644120
    .
67. PMID 19644100
    .
68. PMID 10740722
    .
69. ^ Rosenberg L., de la Torre J. (2006). Wound Healing, Growth Factors. Emedicine.com. Accessed 20 January 2008.
70. S2CID 9612298
    .
71. PMID 9785465
    .
72. doi:10.1053/j.ctep.2004.08.006
    .
73. ^ ^{a b} Souppouris A (23 May 2013). "Scientists identify cell that could hold the secret to limb regeneration". the verge.com. Researchers have identified a cell that aids limb regrowth in Salamanders. Macrophages are a type of repairing cell that devour dead cells and pathogens, and trigger other immune cells to respond to pathogens.
74. ^
    PMID 23690624
    .
75. S2CID 4285140
    .
76. PMID 5905254
    .
77. PMID 29511065
    .
78. PMID 24792964
    .
79. PMID 25480297
    .
80. PMID 25036630
    .
81. PMID 30955887
    .
82. S2CID 210043405
    .
83. ISBN 978-1-4939-1310-7
    .
84. PMID 33669824
    .
85. PMID 25703560
    .
86. ISBN 978-0-8385-8529-0
    .
87. PMID 22479654
    .
88. S2CID 8952545
    .
89. PMID 24501331
    .
90. S2CID 250475623
    .
91. doi:10.2217/fvl.10.93
    .
92. PMID 23035819
    .
93. PMID 20371344
    .
94. ^
    S2CID 21924175
    .
95. PMID 17695843
    .
96. S2CID 12722658
    .
97. ^ Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196:254–65.
98. S2CID 80769044
    .
99. PMID 11257139
    .
100. PMID 21654748
     .
101. PMID 23333075
     .
102. PMID 26989197
     .
103. PMID 25753580
     .
104. PMID 23518347
     .
105. PMID 26503691
     .
106. PMID 24209604
     .
107. PMID 25446896
     .
108. PMID 22039576
     .
109. PMID 25716473
     .
110. PMID 20631066
     .
111. PMID 28490665
     .
112. PMID 25082815
     .
113. PMID 24898549
     .
114. PMID 25858805
     .
115. PMID 31076558
     .
116. ^ Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue" Journal of Clinical Investigation 2003; 112:1796–808.
117. PMID 30733616
     .
118. PMID 33774223
     .
119. PMID 25934927
     .
120. PMID 26940592
     .
121. PMID 16150820
     .
122. PMID 26697009
     .
123. ^
     PMID 15630445
     .
124. ^
     PMID 22025201
     .
125. PMID 24942685
     .
126. S2CID 256030791
     .
127. PMID 25035951
     .
128. PMID 33542457
     .
129. PMID 25035951
     .
130. PMID 26330802
     .
131. PMID 37344646
     .

Wikimedia Commons has media related to Macrophages.